Jun
2026
Shanghai New International Expo Center
Visit us
stand E2B76, Pharma Excipients
Zone

Brenntag

About Us

Brenntag is the global market leader in chemicals and ingredients distribution. The company holds a central role in connecting customers and suppliers of the chemical industry. Headquartered in Essen, Germany, Brenntag has more than 17,000 employees worldwide and operates a network of about 700 sites in 78 countries. In 2021, Brenntag generated sales of around 14.4 billion EUR. The two global divisions, Brenntag Essentials and Brenntag Specialties, provide a full-line portfolio of industrial and specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions for a wide range of industries. In the field of sustainability, Brenntag pursues specific goals and is committed to sustainable solutions in its own sector and the industries served. Brenntag shares have been listed at the Frankfurt Stock Exchange since 2010, initially in the MDAX and since September 2021 in the DAX. In addition, the Brenntag SE shares are listed in the DAX 50 ESG and DAX ESG Target. For more information, visit www.brenntag.com.  

  • Country/Region:
    Germany
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    5000+
Company types
Distributor/Import Export
Primary activities
Analytical Services
Biopharmaceutical
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Ingredients Distributor/Buyer
Regulatory Affairs
Supply Chain
Transport/Logistics/Distribution
Contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E2B76, Pharma Excipients

Products Featured at CPHI & PMEC China 2026

Brenntag Holding GmbH Resources (1)

  • Video How Brenntag is approaching the current trends in the biopharma market

    In this interview with Gearoid O'Rourke, Director Value Added Services Pharma EMEA, for Brenntag speaks about the current trends in the global and European biopharmaceutical industry, and the supplier trends relevant for manufacturers and distributors. Finally O'Rourke covers what trends Brenntag envisages in the future for suppliers to the biopharmaceutical industry.